Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

pillsphotos1

The pharmaceutical ethics of drug-price increases

October 30, 2015 Medical Communications, Research and Development Drug pricing, Turing Pharma, ethics

What is an ‘ethical’ price for a drug?Last month Turing Pharmaceuticals, a start-up run by a former hedge-fund manager, raised …
Feature
Coins

ANALYSIS: The challenges of forecasting biosimilar sales across Europe

October 29, 2015 Manufacturing and Production, Research and Development, Sales and Marketing biologics, biosimilars, generics, patent cliff, patents, sales, sales forecasts

The introduction of biologic medicines revolutionised treatment in several key therapeutic areas, including oncology, diabetes and various inflammatory diseases.The landscape …
Feature

Bayer posts strong earnings growth

October 29, 2015 Manufacturing and Production, Research and Development, Sales and Marketing

Sales across the Bayer group rose by 1.9% in the third quarter of 2015 to €11 billion, according the company’s …
News
novartis

Novartis launches new hypertension program in Ghana

October 29, 2015 Research and Development

The Novartis Foundation and its partners have begun screening patients in a Community-based Hypertension Improvement Project (ComHIP) in Ghana in …
News
jose_joe_almeida

Baxter names José Almeida chairman and chief executive

October 29, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Joe Almeida, José Almeida, baxter

Baxter has named José (Joe) Almeida as the company’s new chairman and chief executive from January 1, 2016. Almeida will …
Appointment
imlygic_amgen

FDA approves first-in-class Amgen melanoma drug

October 28, 2015 Research and Development, Sales and Marketing Amgen, Imlygic, melonoma

The US Food and Drug Administration (FDA) has approved Amgen’s Imlygic for the treatment of melanoma lesions in the skin …
News
Jinarc

Otsuka kidney drug earns first NICE nod

October 28, 2015 Research and Development, Sales and Marketing NHS, NICE, jinarc, kidney disease, tolvaptan

NICE has released final guidance recommending Otsuka’s Jinarc, the first-ever treatment shown to slow progression of life-threatening Autosomal Dominant Polycystic …
News
Merck image

Sales up at MSD while Keytruda hits survival target in late-stage trial

October 28, 2015 Research and Development, Sales and Marketing MSD, Merck, financial results, keytruda, pembrolizumab

Worldwide sales at MSD were $10.1 billion in the third quarter of 2015, a 4% increase after accounting for the …
News
Sativex

Otsuka, GW announce Sativex fails in Phase III cancer pain trials

October 28, 2015 Research and Development, Sales and Marketing Cancer, GX Pharmaceuticals, Otsuka, Sativex, cancer pain, palliative care, phase III, phase III failure

Otsuka and GW Pharmaceuticals cannabis-based drug Sativex failed to show superiority over placebo in two Phase III trials.The studies were …
News
BGMA D-G Warwick Smith

OPINION: ‘More work remains if biosimilars are to fulfil their potential’

October 27, 2015 Manufacturing and Production, Research and Development, Sales and Marketing British Generic Manufacturers Association, NHS, bgma, biosimilars, generics, patent cliff, patents

Despite having a mature generics market which fulfils more than three-quarters of all prescriptions in the UK, and as a …
Feature
George Freeman

Pharma reaction to the Government’s AAR review

October 27, 2015 Manufacturing and Production, Research and Development Accelerated Access Review

The long-awaited interim report on the Government’s Accelerated Access Review has been published.The Government department overseeing the report, the Office …
News
Shire image

New Phase III data puts Shire’s lifitegrast back on track for 2016 launch

October 27, 2015 Research and Development Shire, dry eye disease, lifitegrast

Shire shares rose 6% today as the company reported new positive Phase III trial data for lifitegrast in the treatment …
News
nhsa

North of England secures new ‘centres of excellence’ in ‘precision medicine’

October 27, 2015 Manufacturing and Production, Research and Development NHS, Northern Health Science Alliance, UK

The umbrella group formed by the leading northern universities, teaching hospitals and Academic Health Science Networks – the Northern Health …
News

Revealed: recommendations from the Accelerated Access Review

October 27, 2015 Manufacturing and Production, Research and Development Accelarated Access Review, NHS

Ministers have been urged to introduce conditional approvals for innovative new drugs, and ‘radically new’ central agreements on drug pricing, …
News
gsk_hq

GSK’s Volibris gets pulmonary arterial hypertension approval in Europe

October 26, 2015 Research and Development, Sales and Marketing EMA, GSK

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025